Indeed, assessing ANXA1 expression by immunohistochemistry has been shown to be complicated by a lack of available antibodies that are both specific for ANXA1 and can bind the cleaved form of ANXA1 previously identified in tumour vasculature [37]. This evidence concerns the gene ANXA1 and neoplasm.